Sign In
to Vote &
Create Storyboards.
 

Market News

Location American Market News for 29 June 2014
American Apparel Inc. (NYSEMKT:APP) adopted a poison-pill strategy Saturday to prevent former CEO Dov Charney from seizing control of the company.
Read More
7
0
Pressure appears to be building within the Republican Party to reauthorize the Export-Import Bank rather than letting it expire Sept. 30, The Hill reported. Reps. John Campbell (R-Calif.) and Stephen Fincher (R-Tenn.) ar...
Read More
5
0
The Bank for International Settlements in Basel, Switzerland, Sunday warned investors are driving up the prices of stocks and other assets to dangerous levels in their quest for earning better returns than interest rates...
Read More
0
0

The New Normal of Healthcare Spending

Forbes - 29 Jun 2014 17:54
The New Normal of Healthcare Spending Below is the June 29th "Thoughts from the Frontline" newsletter, republished in full.  
Read More
0
0

Omaxe plans to raise Rs300 crore via equity dilution

livemint.com - 29 Jun 2014 16:58
Omaxe plans to raise Rs300 crore via equity dilution Omaxe to dilute promoters' stake by 8-10% depending on the market conditions
Read More
0
0

The shrinking share of domestic investors

livemint.com - 29 Jun 2014 15:57
The shrinking share of domestic investors Note that the proportion of FII holdings is currently much higher than what it was even at the height of the bull run in 2006 and 2007
Read More
0
0

Good results from Accenture, but they're priced in

livemint.com - 29 Jun 2014 15:51
Good results from Accenture, but they're priced in That the firm beat revenue and bookings estimates indicates signals about the demand environment are positive
Read More
0
0

Ashok Leyland: Is the worst behind it?

livemint.com - 29 Jun 2014 15:30
Ashok Leyland: Is the worst behind it? The street has recognized Ashok Leyland's efforts to improve operating performance and cash flows, but the equity dilution has been a dampener
Read More
0
0

Ranbaxy makes good on its promise

livemint.com - 29 Jun 2014 15:13
Ranbaxy makes good on its promise The launch of Diovan may give confidence to investors that Ranbaxy can make good its commitment of exploiting its US first-to-file pipeline
Read More
0
0

{TITLE}

{PUBLISHER} - {PUBLISHED_DATE}
{TITLE} {CONTENT}
Read More
{VIEWS}
0


Storyboard
Print
{VIEWS}
0
0




Share this Article

Location



Create Storyboard